Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 589

T cells

HIV virus (yellow) infecting a human cell (© Photo by National Cancer Institute on Unsplash/Courtesy of Touro University)
September 26, 2023, 2:05 pm
New research shows previously unidentified pathway used by HIV to infect cells
Study led by professor at Touro University’s Nevada campus sheds light on how AIDS-causing virus enters a cell’s nucleus so it can replicate, finds possible drug countermeasure
By Renee Ghert-Zand
Illustrative image: A cancer patient receives immunotherapy (Elaine Thompson/AP Photo)
June 7, 2023, 1:03 pm
New Israeli technology improves prediction of patient response to immunotherapy
Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval
By Renee Ghert-Zand
An image from the Bar Ilan University lab of Prof. Cyrille Cohen, showing two immune cells in green fighting a cancer cell in red, in the new immunotherapy invented there (Cyrille Cohen, Tilda Barliya and Astar Shamul)
January 4, 2023, 4:55 pm
After demonstrating 57% remission rate, Israeli immunotherapy licensed by US firm
Some 85% of patients improved after taking new therapy developed by Bar Ilan and Hadassah; method involves adding artificial molecule to T-cells
By Nathan Jeffay
An eosinophil white blood cell as a 3D illustration (wildpixel via iStock by Getty Images)
September 13, 2021, 6:11 pm
Israeli scientists aim to mobilize allergy-causing cells to fight cancer
Tumors in mice lost half their size when injected with eosinophils, best known for inducing allergies; promising results also seen in human tumor cells in vitro
By Nathan Jeffay
The new Tel Aviv University 'GPS-guided' nanoparticle drug, in blue and green, around an immune cell. (courtesy of Tel Aviv University)
June 29, 2021, 10:28 am
New Israeli ‘GPS’ nano-drug busts inflammation, touted as antibody replacement
Nanoparticles, tested on mice and unveiled in peer-reviewed research, head straight to cells that are inflamed, and either ‘silence’ or edit the gene that is causing inflammation
By Nathan Jeffay
A cytokine storm. (selvanegra via iStock by Getty Images)
June 9, 2021, 5:28 pm
Israeli scientists move closer to averting deadly immune overreaction to COVID
Technion team says it has identified the T-cell mechanism that launches ‘cytokine storms,’ which have caused many coronavirus deaths
By Nathan Jeffay
A doctor shows medical records to cancer patient in hospital ward (iStock)
December 16, 2020, 7:02 pm
Israeli researchers spot new peptides that could point way to slaying cancer
Immunotherapy needs peptides to work, but if a patient has too few, anti-cancer drugs will fall short; discovery of new type by Weizmann Institute-led team could solve problem
By Nathan Jeffay
T cells attacking a cancer cell (frentusha; iStock by Getty Images)
May 26, 2020, 2:31 pm
Some autoimmune diseases are work of overzealous T cells, researchers say
Scientists at Israel’s Weizmann Institute find that these protective cells combat excess hormones in certain organs; when they misread the situation, illness results
By Shoshanna Solomon
T cells attacking a cancer cell (frentusha; iStock by Getty Images)
June 17, 2019, 6:08 pm
Study identifies protein that causes ‘exhaustion’ of immune system cells
Understanding role of TOX protein could pave way to restoring normal function in systems weakened by chronic disease, say researchers from Israel’s Bar-Ilan University and others
By Shoshanna Solomon
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.